BNP Paribas Financial Markets’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$622K	Sell	46,599 -35,337	-43%	-$472K	﹤0.01%	2444
2025 Q1	$835K	Buy	81,936 +35,826	+78%	+$365K	﹤0.01%	2143
2024 Q4	$730K	Buy	+46,110	New	+$730K	﹤0.01%	2265
2022 Q4	–	Sell	-22,427	Closed	-$844K	–	3643
2022 Q3	$844K	Buy	+22,427	New	+$844K	﹤0.01%	1990